Figure 3From: Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar borderPlasma artesunate (a) and dihydroartemisinin (b) concentrations at 1 hour of the first dose in day 1 in patients with sensitive (S) and recrudescence (R) response. Dot lines represent the lower and upper level of 95% CI defined in the sensitive group.Back to article page